{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:09:22Z","timestamp":1793948962038,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO 81670376"],"award-info":[{"award-number":["NO 81670376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1534-3","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T08:44:16Z","timestamp":1528533856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM"],"prefix":"10.1186","volume":"16","author":[{"given":"Mengmeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-7823","authenticated-orcid":false,"given":"Jiangping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"issue":"6","key":"1534_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-017-2228-0","volume":"73","author":"L Goenka","year":"2017","unstructured":"Goenka L, George M, Selvarajan S. End points in heart failure-are we doing it right? Eur J Clin Pharmacol. 2017;73(6):651\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1534_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/cvr\/cvv023","volume":"105","author":"JC Tardiff","year":"2015","unstructured":"Tardiff JC, Carrier L, Bers DM, Poggesi C, Ferrantini C, Coppini R, Maier LS, Ashrafian H, Huke S, van der Velden J. Targets for therapy in sarcomeric cardiomyopathies. Cardiovasc Res. 2015;105(4):457\u201370.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1534_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1046\/j.1365-2362.2001.00804.x","volume":"31","author":"PA Doevendans","year":"2001","unstructured":"Doevendans PA. Unravelling the pathophysiology of heart failure through human genomics. Eur J Clin Invest. 2001;31(5):378\u20139.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"1534_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","volume":"54","author":"JM Bos","year":"2009","unstructured":"Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(3):201\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1534_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O\u2019Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93(5):841\u20132.","journal-title":"Circulation"},{"issue":"2","key":"1534_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11886-000-0010-9","volume":"2","author":"JA Towbin","year":"2000","unstructured":"Towbin JA. Molecular genetics of hypertrophic cardiomyopathy. Curr Cardiol Rep. 2000;2(2):134\u201340.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"1534_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","volume":"104","author":"JG Seidman","year":"2001","unstructured":"Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104(4):557\u201367.","journal-title":"Cell"},{"issue":"9","key":"1534_CR8","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1006\/jmcc.2000.1204","volume":"32","author":"TM Olson","year":"2000","unstructured":"Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2000;32(9):1687\u201394.","journal-title":"J Mol Cell Cardiol"},{"issue":"23","key":"1534_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Kamisago","year":"2000","unstructured":"Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343(23):1688\u201396.","journal-title":"N Engl J Med"},{"issue":"9","key":"1534_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCRESAHA.116.309804","volume":"119","author":"T Kraft","year":"2016","unstructured":"Kraft T, Montag J, Radocaj A, Brenner B. Hypertrophic cardiomyopathy: cell-to-cell imbalance in gene expression and contraction force as trigger for disease phenotype development. Circ Res. 2016;119(9):992\u20135.","journal-title":"Circ Res"},{"issue":"10","key":"1534_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","volume":"287","author":"BJ Maron","year":"2002","unstructured":"Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10):1308\u201320.","journal-title":"JAMA"},{"issue":"2","key":"1534_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1086\/321978","volume":"69","author":"J Schonberger","year":"2001","unstructured":"Schonberger J, Seidman CE. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet. 2001;69(2):249\u201360.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1534_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","volume":"100","author":"D Sayed","year":"2007","unstructured":"Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res. 2007;100(3):416\u201324.","journal-title":"Circ Res"},{"issue":"3","key":"1534_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation. 2007;116(3):258\u201367.","journal-title":"Circulation"},{"issue":"10","key":"1534_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/CIRCRESAHA.115.306624","volume":"117","author":"Y Yang","year":"2015","unstructured":"Yang Y, Del Re DP, Nakano N, Sciarretta S, Zhai P, Park J, Sayed D, Shirakabe A, Matsushima S, Park Y, et al. miR-206 mediates YAP-induced cardiac hypertrophy and survival. Circ Res. 2015;117(10):891\u2013904.","journal-title":"Circ Res"},{"issue":"6","key":"1534_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.healun.2017.02.008","volume":"36","author":"D Scrutinio","year":"2017","unstructured":"Scrutinio D, Conserva F, Passantino A, Iacoviello M, Lagioia R, Gesualdo L. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: a genome-wide prospective study. J Heart Lung Transplant. 2017;36(6):616\u201324.","journal-title":"J Heart Lung Transplant"},{"key":"1534_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2015.05.185","volume":"196","author":"AA Derda","year":"2015","unstructured":"Derda AA, Thum S, Lorenzen JM, Bavendiek U, Heineke J, Keyser B, Stuhrmann M, Givens RC, Kennel PJ, Schulze PC, et al. Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. Int J Cardiol. 2015;196:115\u201322.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1534_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10557-011-6289-5","volume":"25","author":"VK Topkara","year":"2011","unstructured":"Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther. 2011;25(2):171\u201382.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"1534_CR19","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1172\/JCI33099","volume":"117","author":"E Rooij van","year":"2007","unstructured":"van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007;117(9):2369\u201376.","journal-title":"J Clin Invest"},{"issue":"8","key":"1534_CR20","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/jcp.24942","volume":"230","author":"Q Duan","year":"2015","unstructured":"Duan Q, Yang L, Gong W, Chaugai S, Wang F, Chen C, Wang P, Zou MH, Wang DW. MicroRNA-214 is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis. J Cell Physiol. 2015;230(8):1964\u201373.","journal-title":"J Cell Physiol"},{"issue":"11","key":"1534_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrd3864","volume":"11","author":"E Rooij van","year":"2012","unstructured":"van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11(11):860\u201372.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1534_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","volume":"110","author":"EE Creemers","year":"2012","unstructured":"Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110(3):483\u201395.","journal-title":"Circ Res"},{"issue":"25","key":"1534_CR23","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","volume":"58","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(25):2703\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"1534_CR24","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","volume":"27","author":"DP Zipes","year":"2006","unstructured":"Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, et al. ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2013executive summary: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27(17):2099\u2013140.","journal-title":"Eur Heart J"},{"issue":"3","key":"1534_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","volume":"31","author":"S Ikeda","year":"2007","unstructured":"Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genom. 2007;31(3):367\u201373.","journal-title":"Physiol Genom"},{"issue":"10","key":"1534_CR26","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","volume":"114","author":"HY Seok","year":"2014","unstructured":"Seok HY, Chen J, Kataoka M, Huang ZP, Ding J, Yan J, Hu X, Wang DZ. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy. Circ Res. 2014;114(10):1585\u201395.","journal-title":"Circ Res"},{"issue":"9","key":"1534_CR27","doi-asserted-by":"publisher","first-page":"e44744","DOI":"10.1371\/journal.pone.0044744","volume":"7","author":"RD Bagnall","year":"2012","unstructured":"Bagnall RD, Tsoutsman T, Shephard RE, Ritchie W, Semsarian C. Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure. PLoS ONE. 2012;7(9):e44744.","journal-title":"PLoS ONE"},{"issue":"29","key":"1534_CR28","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.1073\/pnas.0811371106","volume":"106","author":"Z Lin","year":"2009","unstructured":"Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA. 2009;106(29):12103\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"1534_CR29","doi-asserted-by":"publisher","first-page":"24262","DOI":"10.1074\/jbc.M701050200","volume":"282","author":"MM Martin","year":"2007","unstructured":"Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. The human angiotensin II type 1 receptor +1166 A\/C polymorphism attenuates microRNA-155 binding. J Biol Chem. 2007;282(33):24262\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"1534_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s00246-014-0901-y","volume":"35","author":"F Wang","year":"2014","unstructured":"Wang F, Yang XY, Zhao JY, Yu LW, Zhang P, Duan WY, Chong M, Gui YH. miR-10a and miR-10b target the 3\u2032-untranslated region of TBX5 to repress its expression. Pediatr Cardiol. 2014;35(6):1072\u20139.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"1534_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/cvr\/cvp015","volume":"82","author":"S Roy","year":"2009","unstructured":"Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009;82(1):21\u20139.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"1534_CR32","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","volume":"100","author":"R Ji","year":"2007","unstructured":"Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007;100(11):1579\u201388.","journal-title":"Circ Res"},{"issue":"10","key":"1534_CR33","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1534_CR34","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2011-08-373886","volume":"119","author":"C Urbich","year":"2012","unstructured":"Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, et al. MicroRNA-27a\/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood. 2012;119(6):1607\u201316.","journal-title":"Blood"},{"issue":"4","key":"1534_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0008-6363(01)00507-7","volume":"53","author":"MM Borren van","year":"2002","unstructured":"van Borren MM, Verkerk AO, Vanharanta SK, Baartscheer A, Coronel R, Ravesloot JH. Reduced swelling-activated Cl(-) current densities in hypertrophied ventricular myocytes of rabbits with heart failure. Cardiovasc Res. 2002;53(4):869\u201378.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1534_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.bjp.0706135","volume":"145","author":"YP Dai","year":"2005","unstructured":"Dai YP, Bongalon S, Hatton WJ, Hume JR, Yamboliev IA. ClC-3 chloride channel is upregulated by hypertrophy and inflammation in rat and canine pulmonary artery. Br J Pharmacol. 2005;145(1):5\u201314.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1534_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yjmcc.2009.07.003","volume":"48","author":"D Xiong","year":"2010","unstructured":"Xiong D, Heyman NS, Airey J, Zhang M, Singer CA, Rawat S, Ye L, Evans R, Burkin DJ, Tian H, et al. Cardiac-specific, inducible ClC-3 gene deletion eliminates native volume-sensitive chloride channels and produces myocardial hypertrophy in adult mice. J Mol Cell Cardiol. 2010;48(1):211\u20139.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1534-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:05:10Z","timestamp":1560020710000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1534"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1534-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,9]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"161"}}